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ABSTRACT
The National Center for Biotechnology Information
(NCBI) Reference Sequence (RefSeq) database is a
collection of genomic, transcript and protein
sequence records. These records are selected
and curated from public sequence archives and
represent a significant reduction in redundancy
compared to the volume of data archived by the
International Nucleotide Sequence Database
Collaboration. The database includes over 16000
organisms, 2.4 10
6 genomic records, 13 10
6
proteins and 2 10
6 RNA records spanning pro-
karyotes, eukaryotes and viruses (RefSeq release
49, September 2011). The RefSeq database is main-
tained by a combined approach of automated
analyses, collaboration and manual curation to
generate an up-to-date representation of the
sequence, its features, names and cross-links to
related sources of information. We report here on
recent growth, the status of curating the human
RefSeq data set, more extensive feature annotation
and current policy for eukaryotic genome annota-
tion via the NCBI annotation pipeline. More informa-
tion about the resource is available online (see
http://www.ncbi.nlm.nih.gov/RefSeq/).
INTRODUCTION
RefSeq integrates an organisms’ genomic, transcript and
protein sequence with descriptive feature annotation and
bibliographic information (1,2). National Center for
Biotechnology Information (NCBI) builds RefSeq from
sequence data available in public archival sequence data-
bases of the International Nucleotide Sequence Database
Collaboration (INSDC, including the DNA Data Bank of
Japan, the European Nucleotide Archive and GenBank).
Unique features of the RefSeq collection includes its
broad taxonomic scope, reduced redundancy, informative
cross-links between nucleic acid and protein records (both
curated and computationally derived) and daily curation
and maintenance. Data linkages include names, protein
domains, orthologs, Enzyme Commission (E.C.)
numbers, phenotypes and disease. Curation and mainten-
ance reﬂect new information and enable the RefSeq col-
lection to support numerous research directions, including
associating sequence with phenotype, providing a stable
and consistent coordinate system to report clinical vari-
ation, comparative genomics and evolutionary studies.
The RefSeq collection is a critical element of additional
resources at NCBI, including dbSNP, dbVar, Gene,
Genomes, Protein Clusters and Map Viewer, enabling
the integration of these resources within and among
organisms.
The RefSeq database is a product of NCBI, a division
of the National Library of Medicine at the US National
Institutes of Health. Records are freely available by
multiple methods, including Internet query, FTP down-
loads, BLAST or scripted query using NCBI’s
E-Utilities. A comprehensive FTP release is available on
a bi-monthly schedule with incremental daily updates
provided between releases. RefSeq records can be
identiﬁed by a distinct accession format which includes
an underscore (‘_’) at the third position. More information
is available online (http://www.ncbi.nlm.nih.gov/books/
NBK21091/).
GROWTH OF THE REFSEQ DATA SET
The comprehensive bi-monthly RefSeq release continues
to grow as new genome and transcript sequence become
publicly available. To support the needs of different
research communities, the release is provided both com-
prehensively in the ‘complete’ directory and based on
general taxonomic groups, mitochondrial or plastid
genomes or plasmid molecules. Release 49 (September
2011) includes records from 16248 species representing
13137813 protein records. Table 1 indicates an annual
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the number of accessions, respectively. Records included
in the release incorporate over 200 million feature anno-
tation links (denoted ‘db_xref=’) to 60 different
Web-based resources. These links allow navigation to
related information from these resources, including those
within NCBI, for e.g. Gene (3), the Conserved Domain
database [CDD (4)], dbSNP (5) and externally, including
nomenclature groups, model organism databases,
protein-focused resources and many more. Links are
managed by collaboration and propagation from the
INSDC records upon which the RefSeq is based.
Microbial organisms as a group account both for the
greatest number of organisms and accessions in Release 49
(Table 2) and displayed the most signiﬁcant annual
growth in number of organisms (85.2%; Table 1). Note,
however, that the number of microbial group accessions
increased by only 18.6%. This value is skewed downward
relative to the growth in the number of organisms or RNA
records. Release 49 actually saw a 156% increase in the
number of microbial RNA records (data not shown); this
reﬂects activity of the RefSeq Targeted Locus project
(http://www.ncbi.nlm.nih.gov/genomes/static/refseqtarget
.html), whose mandate is to provide a single representative
16S ribosomal RNA sequence for bacterial and archaeal
genomes and strains. Release 49 included 6949 organisms
with a single record, 5680 organisms with more than one
but fewer than 100 accessions and 184 organisms with
more than 10000 accessions.
STATUS OF CURATING HUMAN REFSEQ
RECORDS
NCBI staff actively curate several subsets of the RefSeq
collection for Homo sapiens. Curation improves multiple
aspects of the human RefSeq collection by (i) providing
quality reference sequence records for genomic regions,
transcripts and proteins; (ii) maintaining and expanding
functionally relevant information integrated into both
RefSeq records and NCBI’s Gene database;
(iii) communicating and coordinating with international
curation groups to generate a uniﬁed, consistent view of
human genes and their primary products (see the
Consensus CDS (CCDS) project, http://www.ncbi.nlm
.nih.gov/CCDS/CcdsBrowse.cgi); and (iv) supporting the
scientiﬁc community in response to suggestions, questions
or error reports.
Genomic regions
RefSeq provides region-speciﬁc genomic region records
for non-transcribed pseudogenes and for the
RefSeqGene project (http://www.ncbi.nlm.nih.gov/
refseq/rsg/). Pseudogene loci are deﬁned through collab-
oration with the HUGO Gene Nomenclature Committee
[HGNC (6)] downloaded from Pseudogene.org [http://
pseudogene.org/ (7)], or deﬁned by RefSeq curation staff
when reviewing transcripts having more than one
high-quality alignment to the human genome. Curation
involves deﬁning the length and location of the pseudo-
gene locus, determining whether it is transcribed and
providing a link between the pseudogene locus and a func-
tional homolog. As an example, please see NG_002746.2,
which represents a eukaryotic translation initiation factor
pseudogene and the ‘General gene information’ section of
its Gene record (GeneID 1986) where a link to the related
functional gene (EIF5A, GeneID 1984) is provided.
Table 1. Annual Growth of the RefSeq release
Release directory Number of organisms Number of records
Release 43
a Release 49 Increase (%) Release 43 Release 49 Increase (%)
Complete 10854 16248 49.7 15934055 18236994 14.5
Fungi 280 301 7.5 1178671 1319842 12.0
Invertebrate 637 754 18.4 1993670 2232026 12.0
Microbial 5585 10346 85.2 9031974 10711822 18.6
mitochondrion 2266 2654 17.1 34688 40664 17.2
Plant 182 229 25.8 817648 842720 3.1
Plasmid 952 1061 11.4 160065 191018 19.3
Plastid 186 233 25.3 16908 21103 24.8
Protozoa 134 146 9.0 932990 956479 2.5
Vertebrate_mammalian 327 354 8.3 1492157 1587895 6.4
Vertebrate_other 1120 1334 19.1 398084 483449 21.4
Viral 2250 2745 22.0 87759 101664 15.8
aRelease 43 included data available on 7 September 2010; release 49 included data available on 5 September 2011.
Table 2. Distribution of RefSeq release 49 by ftp directory
Release directory Percent of total
Organisms Accessions
Fungi 1.9 7.2
Invertebrate 4.6 12.2
Microbial 63.7 58.7
Mitochondrion 16.3 0.2
Plant 1.4 4.6
Plasmid 6.5 1.0
Plastid 1.4 0.1
Protozoa 0.9 5.2
Vertebrate_mammalian 2.2 8.7
Vertebrate_other 8.2 2.7
Viral 16.9 0.6
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pseudogene RefSeq record based on alignment to a
RefSeq transcript of the functional homolog. The
number of non-transcribed pseudogene records increased
by 7.7% in the past year.
RefSeqGene, as part of the international Locus
Reference Genomic initiative [LRG (8)], provides stable,
gene-speciﬁc human genomic sequence records for
reporting sequence variation in medical records and
locus-speciﬁc databases (see http://www.ncbi.nlm.nih
.gov/refseq/rsg/). The RefSeqGene and LRG records
often represent explicitly only a subset of the known
mRNA and coding regions. Identiﬁcation of the sequences
to use as standards depends on evaluation by the user
base, but usually corresponds to the RefSeq transcript
and protein records that have already been curated and
reviewed by RefSeq and CCDS staff. If a question arises,
review of evidence from the stakeholder, the literature and
sequence evidence may result in an update to a
RefSeqGene record, revision of the reference transcripts
and proteins annotated on the RefSeqGene record or add-
itional splice variants to represent in the RefSeq collection
before assigning the LRG identiﬁer. Transcript variants
and protein isoforms not part of the explicit annotation
are represented by alignments which can be seen in
NCBI’s graphical display. The number of RefSeqGene
records grew by 25.8% in the past year. To request a
RefSeqGene for a gene, contact rsgene@ncbi.nlm.nih.gov.
Transcripts and proteins
Transcripts and proteins are an important focus for
curation at NCBI. This data set has two major
categories—the ‘model’ subset generated directly by
NCBI’s genome annotation pipeline and the ‘known’
subset maintained independently of the genome annota-
tion process using a combination of automated analyses
and manual review. These subsets can be distinguished by
the accession number preﬁx (models begin with ‘X’) as
well as by the annotation in the COMMENT block of
the record when viewed in ﬂatﬁle format (see http://
www.ncbi.nlm.nih.gov/books/NBK21091/ for additional
details). Records in the model subset are created or
updated only upon whole-genome re-annotation but
may be removed from the collection following manual
review between such updates. The human model set was
reviewed last year, which resulted in revision of the gene
type designation (e.g. protein-coding, non-coding, pseudo-
gene, etc.), replacement of model records with known
records and removal of records considered to be insufﬁ-
ciently supported. For example, 2068 model RefSeqs met
the evidence criteria to be replaced by a known RefSeq
type in the 1-year period between releases 43 and 49.
A series of status codes are annotated on the known
RefSeq data set to indicate information about the level
of curation (these codes are not applicable for the model
record subset). Records with a status of either ‘validated’
or ‘reviewed’ are considered to be curated. As of RefSeq
release 49, 92.5% of the human protein coding transcripts
(and their associated proteins) are tracked with a curated
status, and 57.2% of the non-coding transcripts are
tracked with a curated status (Table 3). This includes
curation to add or update over 7500 human transcript
records between releases 43 and 49. RefSeq continues to
represent protein-coding regions that are considered to be
full length, and transcripts that are considered to be at
least near complete. Transcripts that are obviously
partial are not represented but are presented in NCBI’s
genome browser (Map Viewer).
NCBI staff coordinates closely with other major data-
bases and curation groups to maximize consistent data
representation at NCBI and other web sites. The
Consensus Coding Sequence collaboration [http://www
.ncbi.nlm.nih.gov/projects/CCDS/CcdsBrowse.cgi (9)] is
a central hub for curation of protein-coding loci and all
members must agree to updates affecting the genomic
coordinates of a CDS. Ambiguous or complex cases are
discussed among CCDS members in light of available sup-
porting evidence and published reports to achieve consen-
sus on the likely annotated protein product. CCDS review
often includes communication and coordination with the
HGNC, UniProt or the Genome Reference Consortium
[http://www.ncbi.nlm.nih.gov/projects/genome/assembly/
grc/ (10)] when annotation cannot be well represented due
to a concern over the sequence represented in the reference
human genome assembly. The human CCDS data set was
updated twice in the past year, adding 2126 CCDS IDs for
456 genes. The database currently includes 26473 distinct
human protein identiﬁers corresponding to 18471 genes
and is available at http://www.ncbi.nlm.nih.gov/CCDS/.
In addition to ongoing review of transcripts and
proteins, several changes affecting the content of RefSeq
transcript and protein records were implemented recently.
These include:
. new policy for management of protein names;
. new policy for management of readthrough (con-
joined) transcripts;
. expanded representation of non-coding RNAs to
include microRNAs; and
. expanded feature annotation for transcript and protein
records.
Protein names. RefSeq is in the process of adopting
UniProtKB (11) guidelines for protein naming (http://
www.uniprot.org/docs/gennameprot) for both prokary-
otic and eukaryotic records. Implementation of this
Table 3. Current status of human transcripts and proteins
Type Accessions in Release 49
Total Curated
a Percent
curated
Known protein-coding transcripts 31933 29531 92.5
Model protein-coding transcripts 1118 NA
Known non-coding transcripts 5932 3396 57.2
Model non-coding transcripts 3762 NA
Total 42745 32927 77.0
aCurated records have a review status of ‘Validated’ or ‘Reviewed’
which is not applied to model RefSeq records.
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For prokaryotic proteins, protein name curation occurs in
conjunction with NCBI’s Protein Clusters resource
(http://www.ncbi.nlm.nih.gov/proteinclusters). For verte-
brate proteins associated in NCBI’s Gene database with
a related Swiss-Prot accession number, the Swiss-Prot
preferred name is used verbatim. For some vertebrate
RefSeq records, a distinct protein name continues to be
provided if a Swiss-Prot name is not available, or one does
not adhere to the revised UniProt guidelines.
Readthrough transcripts. Transcripts representing exons
from what are typically considered to be neighboring,
yet distinct loci pose a particular challenge for curation.
This category of data resulted in conﬂicting annotation,
requiring extensive discussion among the CCDS collabor-
ation members, as well as HGNC. NCBI and the CCDS
collaboration recently deﬁned an annotation policy that
tracks most readthrough transcript as a distinct locus as it
is not solely the product of either of the two underlying
loci. This approach improves consistency of the gene
extent annotated for the two smaller loci while also reﬂect-
ing the transcriptional complexity of the region. RefSeq
opts to annotate the readthrough transcript when it
appears to be full length and there is a minimum of two
independent lines of support for the readthrough event.
The Gene database reports this transcriptional complexity
in the ‘General gene information’ section of the record.
Examples can be found using available Gene queries [e.g.
‘readthrough parent’ (properties)]. In the last year, RefSeq
curators reviewed the data reported in the ConjoinG
database (12) to expand representation of this type.
RefSeq currently tracks 120 human loci as an instantiated
readthrough locus tracked with a distinct GeneID (for
example, NME1-NME2, Gene ID 654364), and 358 loci
with any type of readthrough association which includes
reports of readthrough transcripts that do not meet the
requirements to represent in RefSeq (for example,
GeneID 6728).
Non-protein-coding transcripts. RefSeq representation of
non-coding RNAs grew by 30% between September
2010 and 2011. Non-coding transcripts are managed in
part by downloading other publicly available data sets
including that available from miRBase http://www
.mirbase.org/ (13). MicroRNAs, represented in RefSeq
as the stem–loop precursor product with feature annota-
tion of the functional RNA product, currently number
6848 records, 1409 of which are for human. Other types
of functional RNAs, for instance small nucleolar RNAs,
may be initially deﬁned by HGNC, or by NCBI curation
staff. Long non-coding transcripts, including splice
variants, have been added to the database as well. Some
of these include transcripts considered unlikely to encode a
protein for several reasons, including non-sense-mediated
decay issues, inhibitory alternative open reading frames or
an alternate splice variant for which there are concerns
about signiﬁcant protein truncation or numerous
upstream ORFs. There are currently 6057 non-coding
transcripts for 4421 human genes, including 1134
non-coding transcripts for 797 human protein-coding loci.
Expanded feature annotation. RefSeq feature annotation
has expanded to indicate localization or function, and to
highlight details of the sequence considered during manual
review. For many years, RefSeq protein records have dis-
played protein annotation computed by NCBI’s CDD
group, including protein domains, intra- or inter-
molecular binding sites and metal-binding sites. While
some signal peptide, mature peptide and other features
have been manually annotated by NCBI staff, these
features are now also propagated from UniProtKB/
Swiss-Prot records and predicted by SignalP 4.0 (14).
Criteria for propagation include a high-quality alignment
and conﬁrmation that the sequence and feature length are
consistently maintained. Feature types that are already
provided by the CDD group are not propagated. The
source of the annotated feature is indicated with a ‘/infer-
ence’ qualiﬁer which cites SignalP4.0 or with a note
‘propagated from UniProtKB/Swiss-Prot’ and an indica-
tion of the Swiss-Prot accession number (for example, see
NP_001028219.1, NP_001171622.1).
Protein-coding RefSeq transcripts now display evidence
for the 50 completeness of the annotated coding region
following a computational search for an in-frame stop
codon upstream of the annotated start codon. Identiﬁed
stop codons are annotated with a misc_feat (see Figure 1
and NM_145204.3). Non-protein-coding transcripts,
when provided for a protein-coding gene, are also compu-
tationally analysed to identify an open reading frame that
shares the same start codon as a protein-coding transcript
(for that gene) but that renders the transcript a candidate
for non-sense-mediated mRNA (NMD) decay. Putative
NMD ORFs are annotated with a misc_feat (see
NR_040252.1). Misc_feat annotation is also added to a
non-coding transcript if it contains an upstream ORF
likely to be inhibitory to translation of the predicted
ORF (see CCDS documentation at http://www.ncbi.nlm
.nih.gov/CCDS/docs/CCDS-AUGguidelines.pdf and
NR_003253.1 for an example).
GENOME ANNOTATION POLICY
Assembled genome sequence data are selected for inclu-
sion in RefSeq based on several considerations including
quality and completeness of a sequencing project, phylo-
genetic distance, model organism status, impact on disease
and health studies, and identiﬁed utility to targeted
research projects. Over the last several years, NCBI has
developed robust whole genome annotation pipelines for
both prokaryotes and eukaryotes. The prokaryotic
pipeline has matured to the point that it is routinely
offered as a service to submitters if genome sequences
are submitted to GenBank without annotation. RefSeq
genome representation for prokaryotes is currently
managed by propagating annotation from the primary
genome data in GenBank, calculating annotation for
RefSeq when annotation is not available in GenBank
within 6 months of submission of the genome, supple-
mented with curation to represent rRNAs, tRNAs and
to provide improved protein names based on curated
protein clusters. Eukaryotic genomes are managed based
Nucleic Acids Research, 2012,Vol.40, Database issue D133on general taxonomic groups, availability of submitted
annotation and existence of an active model organism
database. For mammalian genomes included in RefSeq,
genome annotation is always provided using the NCBI
annotation pipeline. For other organisms, RefSeq
genome annotation is propagated from GenBank when
available. Otherwise, annotation is provided using
NCBI’s eukaryotic annotation pipeline if a quality
genome assembly is submitted with no intent to
annotate, or if annotation is not submitted within a rea-
sonable period of time, or is considered to need updating
and the research group is not able to maintain it over time.
When possible, the RefSeq group works with research
communities and model organism databases to provide a
single standard annotation for the reference genome;
examples include Drosophila melanogaster, Arabidopsis
thaliana, Anopheles gambiae, Saccharomyces cerevisiae
and Escherichia coli K-12.
FUTURE DIRECTIONS
One of the short-term goals for the RefSeq group is to be
more transparent with regard to curation decisions and
support evidence used. The expanded transcript feature
annotation mentioned above is a small step in this direc-
tion that will be further extended. Curators and program-
mers supporting the vertebrate RefSeq data set store a
wide variety of gene and transcript data attributes that
are potentially of use to consumers of the RefSeq data
set. Attribute categories, and available stored data, are
being reviewed and a subset will be selected for reporting
in a structured comment on RefSeq records. Examples of
stored attributes include reported RNA editing, potential
alternate translation initiation codons, loci reported to be
imprinted, use of non-AUG initiation codons and more.
In addition, the vertebrate RefSeq group is working on
reporting more explicit information about the underlying
support for the exon combination that is instantiated in a
RefSeq transcript record, to highlight proteins that are
highly conserved, and to provide a comparison utility to
evaluate putative functional consequence among tran-
script variants.
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Figure 1. NM_145204.3 is shown in the Nucleotide Graphical display format. The display was conﬁgured to show the six-frame translation track
restricted to the sense strand, and to add three markers highlighting the annotated upstream in-frame stop codon, the translation initiation codon
and a second in-frame AUG codon located further downstream. The observation of a stop codon upstream of, and in the same reading frame,
suggests the annotated CDS is 50 complete.
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